Clinical trial · Observational
Comprehensive Assessment of Head and Neck Cancer Survivors
A Comprehensive Assessment of Adult Head and Neck Cancer Survivors (A Pilot Study)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer survivorship has dramatically improved within the last four decades and a greater number of Americans are living after cancer diagnosis. An increase in the number of survivors has highlighted the need to investigate the quality of life experienced by these survivors. While Survivorship research has improved our understanding of the challenges faced by some cancer survivors, there is a paucity of research on the functional and cognitive health status of head and neck cancer survivors. The purpose of this study is to evaluate the functional and cognitive changes that occur in head and neck cancer patients as a result of cancer treatment, in an attempt to increase our understanding of the complex interactions between cancer treatment, comorbid health ailments and quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Newly-diagnosed Head and Neck Cancer
Primary outcomes (1)
- measure
- Functional and Cognitive health status
- timeFrame
- At the time of cancer diagnosis and Within 1 month of cancer therapy
Secondary outcomes (1)
- measure
- Assess the effectiveness of novel performance-based tests in detecting subtle functional and cognitive health status changes
- timeFrame
- At the time of cancer diagnosis and Within 1 month of cancer therapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects must be 40 years of age or older. * Subjects must be able to read, write and speak English fluently. * Subjects must be newly diagnosed with head and neck squamous cell cancer. * Subjects must not have already had treatment for this cancer diagnosis. * Subjects must be anticipated to receive at least one of the following types of therapy: surgery, chemotherapy or radiation. Exclusion Criteria: * Subjects with prior cancer diagnoses who have evidence of active disease. * Subjects who have received cancer treatment within the past year. * Subjects who have received chemotherapy or radiation treatment within the past year (for any disease state). * Life expectancy of less than 3 months. * Subjects with melanoma or other non-squamous cell cancer. * Subjects who score \>9 on Short Blessed Test (SBT) at baseline. * Subjects who are unable to complete all of the required forms and tasks at baseline, either because of cognitive deficits or physical limitations. * Any medical condition the PI determines to affect safe study participation.
References
Publications (0)
Data not yet available